Selectis Health, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
Selectis Health, Inc. (GBCS) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $31.39 thousand as of 2021-12-31, per its 10-K filed 2023-06-30.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2023-06-30
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $31.39K.
- 2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $31.39K; Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed $426.57K.
- 2019-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $428.41K.
- 2018-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $369.59K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed |
|---|---|---|
| 2021-12-31 | $31.39K 10-K · filed 2023-06-30 | |
| 2020-12-31 | $31.39K 10-K · filed 2022-08-26 | $426.57K 10-K · filed 2021-03-31 |
| 2019-12-31 | $428.41K 10-K · filed 2021-03-31 | |
| 2018-12-31 | $369.59K 10-K · filed 2020-07-10 | |
| 2017-12-31 | $285.09K 10-K · filed 2019-04-16 | |
| 2016-12-31 | $182.54K 10-K · filed 2018-04-24 |